FDAnews
www.fdanews.com/articles/115550-irbs-targeted-in-undercover-congressional-investigation

IRBs Targeted in Undercover Congressional Investigation

March 19, 2009
The Government Accountability Office (GAO) is scheduled to report on its undercover investigation of the institutional review board (IRB) system at a hearing next week before a House subcommittee. One of the companies caught up in the investigation is Coast IRB, which said it had notified federal and state officials of a fraudulent clinical trial before the GAO disclosed what Coast calls a “sting” operation.
Clinical Trials Advisor